Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA note about a 2017 NIH grant/contract was added, and the site revision was updated to v3.6.6, replacing v3.6.5.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page's revision tag changed from v3.6.4 to v3.6.5, representing a new revision in the page's version history rather than a change to study content.SummaryDifference0.0%

- Check46 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a routine platform/content-management update.SummaryDifference0.0%

- Check68 days agoChange DetectedPublications section updated with a new ATHENA MONO publication citation by Kristeleit et al. (Ann Oncol. 2026). The revision tag was updated from v3.6.2 to v3.6.3.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page’s revision tag was updated to v3.6.2, replacing v3.6.0, indicating a minor maintenance update with no changes to the study information visible to users.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page now indicates that recruitment is no longer open to participants and adds new Help/Navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment label and updates the revision note to v3.6.0.SummaryDifference0.1%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.